Abbott Laboratories (SWX:ABT)
Switzerland · Delayed Price · Currency is CHF 98.00
0.00 (0.00%)
At close: Jan 30, 2026
Abbott Laboratories Market Cap
Abbott Laboratories has a market cap or net worth of 146.53 billion as of January 30, 2026. Its market cap has decreased by -18.24% in one year.
Market Cap
146.53B
Enterprise Value
150.81B
Revenue
35.15B
Ranking
n/a
PE Ratio
28.32
Stock Price
98.00
Market Cap Chart
Since January 2, 1968, Abbott Laboratories's market cap has increased from 636.28M to 146.53B, an increase of 22,928.55%. That is a compound annual growth rate of 9.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 141.61B | -18.02% |
| Dec 31, 2025 | 172.75B | -2.83% |
| Dec 31, 2024 | 177.78B | 10.48% |
| Dec 29, 2023 | 160.91B | -9.10% |
| Dec 30, 2022 | 177.01B | -19.55% |
| Dec 31, 2021 | 220.03B | 32.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 295.96B |
| Novartis AG | 219.28B |
| Lonza Group AG | 37.50B |
| Galderma Group AG | 33.93B |
| Alcon | 30.39B |
| Sandoz Group AG | 26.48B |
| Straumann Holding AG | 14.61B |
| Sonova Holding AG | 12.61B |